Role Of A DNA Helicase, Recql4, In Haematopoiesis, Skeletal Biology And Malignancy
Funder
National Health and Medical Research Council
Funding Amount
$750,701.00
Summary
We are interested in understanding how a gene involved in familial cancer works. Mutations in this gene cause patients to develop a range of cancers in their blood and skeleton. We are seeking to understand how this gene functions so that we can understand how the cancers form in these families and also how sporadic cancer forms.
An International Whole Genome Study To Definitively Map Heritable Risk In Sarcomas
Funder
National Health and Medical Research Council
Funding Amount
$836,550.00
Summary
We want to understand why some people get sarcomas, and others do not. This is likely due to genetic causes, because these cancers affect the young. We now have the tools to address this question, and have created the largest and best characterised study of sarcoma families in the world upon which to apply these tools. This project will create an enduring foundation for research into the genetic basis of sarcomas for the next 20 years.
Defining The Genomic And Therapeutic Landscape Of Familial Breast Cancer
Funder
National Health and Medical Research Council
Funding Amount
$1,146,096.00
Summary
As a cancer develops it accumulates alterations (mutations) in its DNA. Some of these alterations lead to enhanced tumour growth, whilst others provide insight into normal processes that have gone wrong to enable the tumour to arise. We will use DNA sequencing and mathematical approaches to characterise these alterations and to identify therapeutic targets in breast tumours arising in patients with an inherited predisposition to develop cancer.
Genome Engineered, Preclinical Models Of Serrated Colorectal Cancer To Fast-track A High Sensitivity, Early Detection Test
Funder
National Health and Medical Research Council
Funding Amount
$593,854.00
Summary
1 in 12 Australians will develop colorectal cancer. Here we use information about changes to the genetic (inherited) material of these cancers to develop new, complex models of this disease. This teaches us about what those changes do, and highlights important targets for future drug therapies. We are also developing a better test to detect hidden pre-cancers that are not well detected by our current population screening strategy, to help reduce deaths from this disease.
Novel Therapeutic Approaches To Ovarian Clear Cell Cancer
Funder
National Health and Medical Research Council
Funding Amount
$500,920.00
Summary
Our study aims to develop novel therapies for clear cell ovarian cancer, a disease that is generally resistant to conventional therapies. We have found unexpected parallels between kidney cancer and ovarian clear cell cancer, and this has been used to better treat patients. This study investigates the underlying molecular changes the control ovarian clear cell cancer growth.